MARY NASSAR: Open Payments
NPI 1811769441 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,063 in 64 payments from 14 companies in 2025. Trend: 2023 $138 · 2024 $453 · 2025 $1,063
Food & beverage: $1,063
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $386 |
| Novo Nordisk Inc | 12 | $201 |
| PFIZER INC. | 6 | $107 |
| Lilly USA, LLC | 5 | $86 |
| Exact Sciences Corporation | 3 | $56 |
| Phathom Pharmaceuticals, Inc. | 2 | $53 |
| Amgen Inc. | 2 | $34 |
| Antares Pharma, Inc. | 1 | $29 |
| ABIOMED | 1 | $25 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
Products named: VRAYLAR, QULIPTA, Wegovy, ELIQUIS, Ozempic, Cologuard Collection Kit, VOQUEZNA, MOUNJARO.
Industry payments across PA — which companies pay providers there.
